Digia Oyj (DIGIA)
Nasdaq Helsinki · Finland · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 5.140 |
|---|---|
| 52-week range | 4.800 – 6.860 |
| Return, 1 month / 3 months | −1.2% / −14.0% |
| Return, 1 year / 3 years | −12.7% / +15.1% |
| Trend | Below its 200-day average |
| RSI (14) | 53 |
| Volatility (1 year) | 26.4% |
| Worst drawdown (1 year) | -25.6% |
| Average daily value traded | 0.07M EUR |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Digia Oyj is a Finnish software and information technology services company based in Helsinki. It supplies enterprise software systems and related services, including consulting, integration and the maintenance of business applications. Its customers are mainly organisations in the public and private sectors that rely on these systems for their daily operations. Digia also develops and supports software products for financial management and enterprise resource planning, and it provides digital service development for its clients.
On this site Digia Oyj appears as a stock on the Nasdaq Helsinki (Finland), code DIGIA, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Digia Oyj (DIGIA) trades on the Nasdaq Helsinki in Finland. It last closed at EUR 5.140 on 27 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 116 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.7% and over the last three months it fell 14.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Helsinki
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.4% | ||
| From 52-week high | -24.0% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.0% | ||
| 6-month return | -12.6% | ||
| 12-month return, skipping the last month | -11.7% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.6% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.07M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +5.5% |
|---|---|
| 1 month | −1.2% |
| 3 months | −14.0% |
| 6 months | −12.6% |
| 1 year | −12.7% |
| 3 years | +15.1% |
| 5 years | −12.2% |
Signals
| 50-day / 200-day average | 5.303 / 5.738 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.117 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Mar 2026 | EUR 0.1900 |
| 28 Mar 2025 | EUR 0.1800 |
| 21 Mar 2024 | EUR 0.1700 |
| 24 Mar 2023 | EUR 0.1700 |
| 22 Mar 2022 | EUR 0.1700 |
| 18 Mar 2021 | EUR 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Helsinki; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.